NL142157B - Werkwijze ter bereiding van een therapeutisch preparaat, alsmede werkwijze ter bereiding van een daarbij te gebruiken steroide. - Google Patents

Werkwijze ter bereiding van een therapeutisch preparaat, alsmede werkwijze ter bereiding van een daarbij te gebruiken steroide.

Info

Publication number
NL142157B
NL142157B NL646406614A NL6406614A NL142157B NL 142157 B NL142157 B NL 142157B NL 646406614 A NL646406614 A NL 646406614A NL 6406614 A NL6406614 A NL 6406614A NL 142157 B NL142157 B NL 142157B
Authority
NL
Netherlands
Prior art keywords
preparation
steroid
procedure
therapeutic
therapeutic preparation
Prior art date
Application number
NL646406614A
Other languages
English (en)
Dutch (nl)
Other versions
NL6406614A (xx
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of NL6406614A publication Critical patent/NL6406614A/xx
Publication of NL142157B publication Critical patent/NL142157B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
NL646406614A 1963-06-11 1964-06-11 Werkwijze ter bereiding van een therapeutisch preparaat, alsmede werkwijze ter bereiding van een daarbij te gebruiken steroide. NL142157B (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB23223/63A GB1047518A (en) 1963-06-11 1963-06-11 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB362364 1964-01-28

Publications (2)

Publication Number Publication Date
NL6406614A NL6406614A (xx) 1964-12-14
NL142157B true NL142157B (nl) 1974-05-15

Family

ID=26238483

Family Applications (2)

Application Number Title Priority Date Filing Date
NL646406614A NL142157B (nl) 1963-06-11 1964-06-11 Werkwijze ter bereiding van een therapeutisch preparaat, alsmede werkwijze ter bereiding van een daarbij te gebruiken steroide.
NL646406615A NL141378B (nl) 1963-06-11 1964-06-11 Werkwijze ter bereiding van een therapeutisch preparaat, gevormde voortbrengsels, alsmede werkwijze ter bereiding van een daarbij te gebruiken steroid.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL646406615A NL141378B (nl) 1963-06-11 1964-06-11 Werkwijze ter bereiding van een therapeutisch preparaat, gevormde voortbrengsels, alsmede werkwijze ter bereiding van een daarbij te gebruiken steroid.

Country Status (14)

Country Link
US (1) US3312590A (xx)
BE (2) BE649170A (xx)
BR (2) BR6459937D0 (xx)
CH (2) CH457422A (xx)
CY (1) CY544A (xx)
DE (2) DE1443958B1 (xx)
DK (2) DK116205B (xx)
ES (2) ES300811A1 (xx)
FR (1) FR4548M (xx)
GB (1) GB1047518A (xx)
MY (1) MY7000131A (xx)
NL (2) NL142157B (xx)
NO (2) NO125532B (xx)
SE (2) SE320066B (xx)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3475466A (en) * 1965-08-30 1969-10-28 Schering Corp Novel 17,21-diesters of 16alpha-methyl-9alpha,11beta-dichloro-1,4- pregnadienes
US3422193A (en) * 1966-08-11 1969-01-14 Schering Corp 17-mono esters of corticoids
IT1061787B (it) * 1967-03-01 1983-04-30 Vismara Francesco Spa Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
US3694471A (en) * 1970-06-08 1972-09-26 Warner Lambert Pharmaceutical 17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent
DK135267A (xx) * 1971-02-25
US3789121A (en) * 1971-11-26 1974-01-29 Warner Lambert Co 17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
JPS6040439B2 (ja) * 1978-03-29 1985-09-11 大正製薬株式会社 ヒドロコルチゾン誘導体
DE3068965D1 (en) * 1979-11-16 1984-09-20 Sterosynt Ltd 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
US4350690A (en) * 1980-10-27 1982-09-21 Cressington Investments Ltd. Steroid composition
US4346086A (en) * 1981-06-09 1982-08-24 Beiersdorf Aktiengesellschaft Corticosteroid-containing cream
IL66432A0 (en) * 1981-08-04 1982-12-31 Plurichemie Anstalt Process for the preparation of steroidal esters
DE3133081A1 (de) * 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
FR2515041A1 (fr) * 1981-10-26 1983-04-29 Besins Jean Medicament a base de progesterone pour le traitement des affections mammaires
EP0095894A3 (en) * 1982-05-31 1985-01-02 Ohta Seiyaku Kabushiki Kaisha. 6 alpha-methylprednisolone derivatives
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3243482A1 (de) * 1982-11-22 1984-05-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
DE3400188A1 (de) * 1984-01-02 1985-07-11 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 6(alpha),16(alpha)-dimethylkortikoide
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
SK280967B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalačný prístroj
YU48707B (sh) * 1990-03-02 1999-07-28 Glaxo Group Limited Aparat za inhaliranje - inhalator
EP1305329B2 (en) * 2000-08-05 2015-03-18 Glaxo Group Limited 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
BR0209271A (pt) 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
US20040248867A1 (en) * 2001-06-12 2004-12-09 Keith Biggadike Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2537185A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2124944B1 (en) * 2007-03-14 2012-02-15 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors
WO2009045539A2 (en) 2007-10-05 2009-04-09 Nektar Therapeutics Al, Corporation Oligomer-corticosteroid conjugates
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN112358522B (zh) * 2020-05-18 2021-11-16 河南利华制药有限公司 一种倍他米松二丙酸酯的精制方法及倍他米松二丙酸酯
CN111944002A (zh) * 2020-07-29 2020-11-17 河南利华制药有限公司 一种倍氯米松二丙酸酯中间体及制备方法
CN116023425B (zh) * 2023-03-28 2023-06-20 南京师范大学 曲安西龙衍生物及其医药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147249A (en) * 1961-06-13 1964-09-01 Vismara Francesco Spa 17alpha, 21-substituted methylenedioxy steroids and methods therefor
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden

Also Published As

Publication number Publication date
BE649170A (xx) 1964-12-11
DE1443958B1 (de) 1970-01-02
BR6459936D0 (pt) 1973-08-02
DK116128B (da) 1969-12-15
DK116205B (da) 1969-12-22
SE313562B (xx) 1969-08-18
ES300811A1 (es) 1962-12-16
NO125532B (xx) 1972-09-25
DE1443957B1 (de) 1970-01-02
FR4548M (xx) 1966-11-02
BR6459937D0 (pt) 1973-08-07
NO125533B (xx) 1972-09-25
CY544A (en) 1970-07-02
ES300814A1 (es) 1964-12-01
NL141378B (nl) 1974-03-15
CH450410A (de) 1968-01-31
US3312590A (en) 1967-04-04
CH457422A (de) 1968-06-15
GB1047518A (en) 1966-11-02
BE649171A (xx) 1964-12-11
MY7000131A (en) 1970-12-31
SE320066B (xx) 1970-02-02
NL6406615A (xx) 1964-12-14
NL6406614A (xx) 1964-12-14

Similar Documents

Publication Publication Date Title
NL142157B (nl) Werkwijze ter bereiding van een therapeutisch preparaat, alsmede werkwijze ter bereiding van een daarbij te gebruiken steroide.
NL128626C (nl) Werkwijze ter bereiding van polyurethanen.
NL143551B (nl) Werkwijze ter bereiding van een tetrakosapeptide.
NL288147A (nl) Werkwijze ter bereiding van gecombineerde schuimstoffen
NL140398B (nl) Werkwijze ter bereiding van een margarine met verbeterde braadeigenschappen.
NL287692A (nl) Werkwijze ter bereiding van kleurstoffen
NL140838B (nl) Werkwijze ter bereiding van alfa-alkylideenacylnaftyloxyderivaten.
NL279996A (nl) Werkwijze ter bereiding van roet.
NL140236B (nl) Werkwijze ter bereiding van farmacologisch werkzame sulfamylantranilzuurderivaten.
NL6402927A (nl) Werkwijze voor de bereiding van een verbeterde zilverkatalysator
NL139235B (nl) Werkwijze ter bereiding van een geneesmiddel met antiviruswerking, en van daarvoor geschikte therapeutisch werkzame heterocyclische verbindingen.
NL274560A (nl) Werkwijze ter bereiding van pigmenten
NL148324B (nl) Werkwijze ter bereiding van een geneesmiddel met gestagene werking.
IL21864A (en) Process for the preparation of steroids of the pregnane series
BE613936A (nl) 3alpha-amino-pregnaanverbindingen
NL141863B (nl) Werkwijze ter bereiding van acrylonitrile.
NL141331B (nl) Werkwijze ter vervaardiging van een halfgeleiderinrichting en halfgeleiderinrichting vervaardigd volgens deze werkwijze.
BR6241102D0 (pt) Processo de preparacao de 19-nor esteroides 17-cetonicos
NL143224B (nl) Werkwijze ter bereiding van een benzopyridocolinederivaat.
NL151379B (nl) Werkwijze ter bereiding van een therapeutisch preparaat alsmede werkwijze ter bereiding van de daarbij te gebruiken actieve lincomycinederivaten.
BE615712A (nl) Nieuwe 19-nor-steroidverbindingen
CH459197A (de) Verfahren zur Herstellung von 7a, 16a-Dialkyl-steroiden der Pregnanreihe
BE612592A (nl) C-nor steroiden
NL138942B (nl) Werkwijze ter bereiding van 19-nor-steroiden.
DK108859C (da) Fremgangsmåde til fremstilling af estere af sulfoacetater af androstan- og estranrækken.

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: GLAXO

V4 Discontinued because of reaching the maximum lifetime of a patent